- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Thomas J. Spulak
News 44 results
In the News · Source: CNN
In the News · Source: National Law Journal
February 9, 2023
Tom Spulak discusses how the role of House general counsel has evolved over the years
In the News · Source: HFMA
Cases & Deals
December 23, 2022
K&S Advises Daniel Anderl Judicial Protection Project
Events 29 results
Conference
March 20, 2023
32nd Annual King & Spalding Health Law & Policy Forum
Conference
March 8, 2023
California Life Sciences Summit
Webinar
January 19, 2023
A New Year, A New Day - What’s Next for Healthcare Policy and Oversight in the New Congress
Conference
November 1, 2022
Pharmaceutical University 2022
Insights 50 results
Client Alert
March 6, 2023
U.S. Commerce Department Launches First CHIPS for America Funding Opportunity
Client Alert
February 13, 2023
U.S. International Trade Commission to Investigate Potential Waiver of International Intellectual Property Rights for COVID-19 Diagnostics and Therapeutics
Client Alert
August 11, 2022
The CHIPS Plus Act Promises Support and Incentives for Semiconductor Manufacturing in the United States
Client Alert
August 10, 2022
The Inflation Reduction Act Clears the Senate